澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ONCOSIL MEDICAL LTD

0.695

-0.005-0.71%

成交量：12.99万

成交额：9.14万

市值：2,550.90万

市盈率：-1.45

高：0.720

开：0.710

低：0.690

收：0.700

52周最高：1.810

52周最低：0.370

股本：3,670.36万

流通股本：2,777.08万

量比：3.86

换手率：0.47%

股息：- -

股息率：- -

每股收益(TTM):-0.479

每股收益(LYR):-0.479

净资产收益率：-268.15%

总资产收益率：-78.85%

市净率：5.11

市盈率(LYR):-1.45

数据加载中...

总览公司新闻资讯公告

Oncosil Medical向FDA提交审批申请

Oncosil Medical宣布暂停交易待公布Tripp-Ffx试验结果及FDA通讯

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/OSL.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","market":"AU","secType":"STK","nameCN":"ONCOSIL MEDICAL LTD","latestPrice":0.695,"timestamp":1791781920000,"preClose":0.7,"halted":0,"volume":129872,"delay":0,"changeRate":-0.00714285714285715,"nameEN":"ONCOSIL MEDICAL LTD","floatShares":27770751,"shares":36703600,"eps":-0.479499,"marketStatus":"未开盘","change":-0.005,"latestTime":"10-12 16:12:00 AEDT","open":0.71,"high":0.72,"low":0.69,"amount":91417,"amplitude":0.042857,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.479499,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.7,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":3.861376704742722,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OSL.AU","preClose":0.7,"auctionPrice":0.695,"auctionVolume":31,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781798736}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","floatShares":27770751,"roa":"-78.85%","roe":"-268.15%","lyrEps":-0.4795,"volumeRatio":3.861376704742722,"shares":36703600,"dividePrice":0,"high":0.72,"amplitude":0.042857,"preClose":0.7,"low":0.69,"week52Low":0.37,"pbRate":"5.11","psRate":"5.01","week52High":1.81,"institutionHeld":0,"latestPrice":0.695,"eps":-0.479499,"divideRate":0,"volume":129872,"delay":0,"ttmEps":-0.479499,"open":0.71,"prevYearClose":0.97,"prevWeekClose":0.7,"prevMonthClose":0.865,"prevQuarterClose":0.865,"fiveDayClose":0.73,"twentyDayClose":0.98,"sixtyDayClose":1.3,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-06-03","symbol":"OSL.AU","defaultRemindTime":1748908800000,"type":"split","dateTimestamp":1748872800000,"forFactor":400,"toFactor":1,"ratio":400},{"market":"AU","date":"2022-05-05","symbol":"OSL.AU","defaultRemindTime":1651708800000,"type":"split","dateTimestamp":1651672800000,"forFactor":987878,"toFactor":1000000,"ratio":0.987878}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSL.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184214672","title":"Oncosil Medical向FDA提交审批申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1184214672","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184214672?lang=zh_cn&edition=fundamental","pubTime":"2026-07-07 16:53","pubTimestamp":1783414416,"startTime":"0","endTime":"0","summary":"Oncosil Medical Ltd已正式向美国食品药品监督管理局（FDA）提交了其设备的商业上市审批申请，标志着该产品正式进入FDA的审查阶段。\n根据流程，FDA预计将在收到提交材料后的45天内完成审查。这一关键步骤的推进，对于该公司未来的商业化进程至关重要。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161454467","title":"Oncosil Medical宣布暂停交易 待公布Tripp-Ffx试验结果及FDA通讯","url":"https://stock-news.laohu8.com/highlight/detail?id=1161454467","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161454467?lang=zh_cn&edition=fundamental","pubTime":"2026-06-04 07:10","pubTimestamp":1780528225,"startTime":"0","endTime":"0","summary":"Oncosil Medical宣布暂停交易，等待公布其Tripp-Ffx临床试验结果以及与美国食品药品监督管理局的相关通讯内容。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}